Impact of the coronavirus 2019 (COVID-19) pandemic on anxiety diagnosis in general practices in Germany.

Little is known about the effects of the coronavirus disease-2019 (COVID-19) pandemic on the diagnosis of anxiety disorder. Therefore, the goal of this study was to compare the number of adults with a diagnosis of anxiety disorder and the number of adults newly diagnosed with anxiety disorder in Ger...

ver descrição completa

Detalhes bibliográficos
Autores: Jacob L, Smith L, Koyanagi A, Oh H, Tanislav C, Shin JI, Konrad M, Kostev K
Formato: artículo
Estado:Versión publicada
Fecha de publicación:2021
País:España
Recursos:Fundació Sant Joan de Déu
Repositorio:r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
OAI Identifier:oai:fsjd.fundanetsuite.com:p18459
Acesso em linha:https://fsjd.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=18459
Access Level:acceso abierto
Palavra-chave:Anxiety disorder
COVID-19
Coronavirus disease 2019
General practices
Germany
Pandemic
id ES_de30baba40e923b2e5a6367bd1d842bd
oai_identifier_str oai:fsjd.fundanetsuite.com:p18459
network_acronym_str ES
network_name_str España
repository_id_str
spelling Impact of the coronavirus 2019 (COVID-19) pandemic on anxiety diagnosis in general practices in Germany.Jacob LSmith LKoyanagi AOh HTanislav CShin JIKonrad MKostev KAnxiety disorderCOVID-19Coronavirus disease 2019General practicesGermanyPandemicLittle is known about the effects of the coronavirus disease-2019 (COVID-19) pandemic on the diagnosis of anxiety disorder. Therefore, the goal of this study was to compare the number of adults with a diagnosis of anxiety disorder and the number of adults newly diagnosed with anxiety disorder in Germany between January-June 2019 and January-June 2020, and to identify potential differences in terms of sociodemographic characteristics, prescriptions and comorbidities between these patients. The study included patients with at least one consultation in one of 1140 general practices in Germany in January-June 2019 and January-June 2020. Sociodemographic characteristics included age and sex, while there were three families of drugs and nine common comorbidities available for the analysis. An increase in the number of patients with anxiety disorder was observed in 2020 compared with 2019 (January: +4%, p = 0.643; February: +4%, p = 0.825; March: +34%, p < 0.001; April: +8%, p = 0.542; May: +2%, p = 0.382; June: +19%, p = 0.043; and March-June: + 19%, p < 0.001). There was also an increase in the number of patients newly diagnosed with anxiety disorder between March-June 2020 and March-June 2019 (11,502 versus 9506; +21%, p-value<0.001). Antidepressants, anxiolytics and herbal sedatives were less frequently prescribed in patients newly diagnosed with anxiety disorder in 2020 than in 2019 (30.4% versus 35.6%, p-value<0.001). Finally, COPD (9.4% versus 7.9%, p-value<0.001) and asthma (11.3% versus 9.7%, p-value<0.001) were more frequent in 2020 than in 2019. Taken these findings together, public health measures are urgently needed to mitigate the negative impact of the COVID-19 pandemic on anxiety disorder.PERGAMON-ELSEVIER SCIENCE LTD2021info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://fsjd.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=18459JOURNAL OF PSYCHIATRIC RESEARCHISSN: 00223956ISSNe: 18791379reponame:r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déuinstname:Fundació Sant Joan de DéuInglésinfo:eu-repo/semantics/openAccessoai:fsjd.fundanetsuite.com:p184592026-05-27T12:37:41Z
dc.title.none.fl_str_mv Impact of the coronavirus 2019 (COVID-19) pandemic on anxiety diagnosis in general practices in Germany.
title Impact of the coronavirus 2019 (COVID-19) pandemic on anxiety diagnosis in general practices in Germany.
spellingShingle Impact of the coronavirus 2019 (COVID-19) pandemic on anxiety diagnosis in general practices in Germany.
Jacob L
Anxiety disorder
COVID-19
Coronavirus disease 2019
General practices
Germany
Pandemic
title_short Impact of the coronavirus 2019 (COVID-19) pandemic on anxiety diagnosis in general practices in Germany.
title_full Impact of the coronavirus 2019 (COVID-19) pandemic on anxiety diagnosis in general practices in Germany.
title_fullStr Impact of the coronavirus 2019 (COVID-19) pandemic on anxiety diagnosis in general practices in Germany.
title_full_unstemmed Impact of the coronavirus 2019 (COVID-19) pandemic on anxiety diagnosis in general practices in Germany.
title_sort Impact of the coronavirus 2019 (COVID-19) pandemic on anxiety diagnosis in general practices in Germany.
dc.creator.none.fl_str_mv Jacob L
Smith L
Koyanagi A
Oh H
Tanislav C
Shin JI
Konrad M
Kostev K
author Jacob L
author_facet Jacob L
Smith L
Koyanagi A
Oh H
Tanislav C
Shin JI
Konrad M
Kostev K
author_role author
author2 Smith L
Koyanagi A
Oh H
Tanislav C
Shin JI
Konrad M
Kostev K
author2_role author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Anxiety disorder
COVID-19
Coronavirus disease 2019
General practices
Germany
Pandemic
topic Anxiety disorder
COVID-19
Coronavirus disease 2019
General practices
Germany
Pandemic
description Little is known about the effects of the coronavirus disease-2019 (COVID-19) pandemic on the diagnosis of anxiety disorder. Therefore, the goal of this study was to compare the number of adults with a diagnosis of anxiety disorder and the number of adults newly diagnosed with anxiety disorder in Germany between January-June 2019 and January-June 2020, and to identify potential differences in terms of sociodemographic characteristics, prescriptions and comorbidities between these patients. The study included patients with at least one consultation in one of 1140 general practices in Germany in January-June 2019 and January-June 2020. Sociodemographic characteristics included age and sex, while there were three families of drugs and nine common comorbidities available for the analysis. An increase in the number of patients with anxiety disorder was observed in 2020 compared with 2019 (January: +4%, p = 0.643; February: +4%, p = 0.825; March: +34%, p < 0.001; April: +8%, p = 0.542; May: +2%, p = 0.382; June: +19%, p = 0.043; and March-June: + 19%, p < 0.001). There was also an increase in the number of patients newly diagnosed with anxiety disorder between March-June 2020 and March-June 2019 (11,502 versus 9506; +21%, p-value<0.001). Antidepressants, anxiolytics and herbal sedatives were less frequently prescribed in patients newly diagnosed with anxiety disorder in 2020 than in 2019 (30.4% versus 35.6%, p-value<0.001). Finally, COPD (9.4% versus 7.9%, p-value<0.001) and asthma (11.3% versus 9.7%, p-value<0.001) were more frequent in 2020 than in 2019. Taken these findings together, public health measures are urgently needed to mitigate the negative impact of the COVID-19 pandemic on anxiety disorder.
publishDate 2021
dc.date.none.fl_str_mv 2021
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://fsjd.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=18459
url https://fsjd.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=18459
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv PERGAMON-ELSEVIER SCIENCE LTD
publisher.none.fl_str_mv PERGAMON-ELSEVIER SCIENCE LTD
dc.source.none.fl_str_mv JOURNAL OF PSYCHIATRIC RESEARCH
ISSN: 00223956
ISSNe: 18791379
reponame:r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname:Fundació Sant Joan de Déu
instname_str Fundació Sant Joan de Déu
reponame_str r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
collection r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869421951739494400
score 15,812429